Kymera Therapeutics Inc. (KYMR)
NASDAQ
Closed
Oct 23, 2026
Day's Range
109.0552 wk Range
55.26Overview - KYMR - Kymera Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
8.37B
P/E (Trailing)
-28.35
P/E (Forward)
-21.21
PEG Ratio
0.81
Price / Sales (TTM)
84.71
Price / Book
5.93
EV / EBITDA
-24.65
Profitability
Profit Margin
-285.33%
Operating Margin
-116.31%
Return on Assets
-15.59%
Return on Equity
-24.15%
Ownership
Shares Outstanding
82.78M
Float
66.03M
Short % of Shares Outstanding
15.33%
Held by Insiders
2.12%
Held by Institutions
119.40%
Price stats
Beta
1.98
50-Day Avg
114.96
200-Day Avg
94.07
Dividends
Payout Ratio
0.00%
Analyst Consensus
24 analysts
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - KYMR - Kymera Therapeutics Inc.
Peers - KYMR - Kymera Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- KYMRNASDAQKymera Therapeutics Inc.8.61BMarket Cap+42.26%52-week change-28.36P/E (Trailing)-285.33%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - KYMR - Kymera Therapeutics Inc.
About
Kymera Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule medicines that use targeted protein degradation to address disease-causing proteins. The company’s work centers on harnessing the body’s natural protein recycling systems to create oral therapies…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
